TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Scandinavian Biopharma Distribution AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
157,077
|
154,382
|
121,790 |
| Financial expenses |
580
|
396
|
502 |
| Earnings before taxes |
27,245
|
30,744
|
31,774 |
| EBITDA |
27,272
|
30,409
|
32,206 |
| Total assets |
78,818
|
83,513
|
67,706 |
| Current assets |
78,576
|
82,411
|
67,269 |
| Current liabilities |
21,858
|
26,606
|
28,006 |
| Equity capital |
1,010
|
965
|
949 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
5
|
4
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
1.3%
|
1.2%
|
1.4% |
| Turnover per employee |
31,415
|
38,596
|
40,597 |
| Profit as a percentage of turnover |
17.3%
|
19.9%
|
26.1% |
| Return on assets (ROA) |
35.3%
|
37.3%
|
47.7% |
| Current ratio |
359.5%
|
309.7%
|
240.2% |
| Return on equity (ROE) |
2697.5%
|
3185.9%
|
3348.2% |
| Change turnover |
2,695
|
32,592
|
27,488 |
| Change turnover % |
2%
|
27%
|
29% |
| Chg. No. of employees |
1
|
1
|
0 |
| Chg. No. of employees % |
25%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.